14.03.2022 - LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the 250th unipolar depression patient has been implanted in the RECOVER clinical study, “A Prospective, Multi-center, Randomized Controlled . Seite 1